Taking statins to lower your 'bad' cholesterol by about 39 mg/dL can reduce your risk of dying from any cause by 9%, and it doesn’t make you more likely to die from cancer or other non-heart problems.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
This claim is based on meta-analyses of randomized controlled trials (e.g., Cholesterol Treatment Trialists’ Collaboration) that show a consistent, dose-dependent reduction in mortality with LDL lowering. The 9% per 1.0 mmol/L figure is a well-replicated quantitative estimate from pooled data. However, the claim implies a direct causal effect of statins, while the observed benefit may reflect LDL lowering regardless of mechanism. The absence of increased non-vascular deaths is also supported by large trials. The verb 'reduces' is slightly definitive; 'is associated with a 9% reduction' better reflects the probabilistic nature of population-level data.
More Accurate Statement
“In individuals without prior vascular disease, each 1.0 mmol/L reduction in LDL cholesterol is associated with a 9% reduction in all-cause mortality, with no significant increase in non-vascular or cancer-related deaths.”
Context Details
Domain
medicine
Population
human
Subject
Individuals without prior vascular disease
Action
reduces
Target
all-cause mortality by 9% per 1.0 mmol/L LDL reduction
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
This big study checked if taking statins to lower bad cholesterol helps people without heart disease live longer — and it did, by about 9% per drop of 1 mmol/L in cholesterol. It also found no increase in cancer or other unrelated deaths, just like the claim said.